Skip to main content

Table 2 Progression criteria for assessing feasibility of trial design

From: A protocol for a randomised controlled, double-blind feasibility trial investigating fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, Learning and Memory in Epilepsy (FLAME trial)

Variable

Progression criteria

Red

Amber

Green

Recruitment

Percentage of participants approached willing to participate

< 5%

5–20%

> 20%

Percentage of participants screened actually recruited

< 50%

50–75%

> 75%

Number of participants recruited

< 8

8–16

> 16

Number of participants recruited within timeframe (1 year)

< 2

2–15

> 15

Retention

Percentage of participants still on study medication at follow-up assessment 1

< 30%

30–60%

> 60%

Percentage of partially active* trial participants at follow-up assessment 1

< 50%

50–80%

> 80%

Percentage of partially active trial participants at follow-up assessment 2

Not subject to progression criteria

Adherence

Pill count (compliance) over 81 days

< 50%

50–80%

> 80%

  1. *This would include participants that have partially withdrawn from the study, for example, stopping study medication but continuing with follow-up assessments